Lorinda Burgess - 17 Jul 2024 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Stephen A. Trowbridge, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
17 Jul 2024
Net transactions value
$0
Form type
4
Filing time
19 Jul 2024, 17:18:29 UTC
Previous filing
14 May 2024
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Award $0 +20,541 +121% $0.000000 37,582 17 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.